about
sameAs
A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial)Antidepressants for agitation and psychosis in dementiaPrevalence of physical and verbal aggressive behaviours and associated factors among older adults in long-term care facilities.Assessment and management of behavioral and psychological symptoms of dementiaDealing with behavioral and psychological symptoms of dementia: a general overview.Individual music therapy for managing neuropsychiatric symptoms for people with dementia and their carers: a cluster randomised controlled feasibility study.Packages of care for dementia in low- and middle-income countries.Aromatherapy and Aromatic Plants for the Treatment of Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer's Disease: Clinical Evidence and Possible Mechanisms.Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic review.Approach to managing behavioural disturbances in dementia.Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design.Aggression in persons with dementia: use of nursing theory to guide clinical practice.Predictors of time to discharge in patients hospitalized for behavioral and psychological symptoms of dementia.ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia.Drug Therapy for Behavioral and Psychological Symptoms of DementiaAntipsychotics for the treatment of behavioral and psychological symptoms of dementia (BPSD)HDAC inhibitors restore the capacity of aged mice to respond to haloperidol through modulation of histone acetylation.Behavioral and psychological symptoms of dementia and their management.Management of Behavioral and Psychological Symptoms of Dementia.The Use of Cannabinoids in Treating Dementia.The Diagnosis and Treatment of Behavioral Disorders in Dementia.Haloperidol inactivates AMPK and reduces tau phosphorylation in a tau mouse model of Alzheimer's diseaseAntipsychotics in Alzheimer's disease: A critical analysis.Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia.Pharmacological treatments for alleviating agitation in dementia: A systematic review and network meta-analysis.Les antipsychotiques pour l’agitation dans les cas de démence.Ayurvedic Medicine for the Treatment of Dementia: Mechanistic Aspects.Antipsychotics for agitation in dementia.Pharmacologic management of behavioral and psychological symptoms of major neurocognitive disorder
P2860
Q21144654-04A1F591-C015-4BA1-8439-68306815E014Q24236550-D594E62B-0196-4968-B609-764D9FCBDEE0Q24816181-1ABB81FC-10D9-42FD-9A2E-85A199A18B60Q28088782-1F2BDE25-3783-4EA0-835A-3DD60434E33DQ30376652-D62FC4D0-C9B3-46D4-BECD-A0FFDF37D3D5Q30376806-81867CFD-0435-4591-8118-EA0AA5AAC0E3Q33514859-4D54B30B-3E7B-4383-9A4E-B42EF2F7B556Q33561116-14EE038B-64AE-41E9-A1F8-D4D16E81D8A8Q34298335-E218CC40-AA4E-4E75-9219-8790307108D5Q34683770-9E431612-E117-4FC9-9A28-124C3892A656Q35185368-701D2922-C9B6-4A82-9305-1D1F244670F2Q36003456-64BEE793-8D0D-4178-9826-EBD51BEDA93EQ36802818-C29DAF5A-C8B7-4785-92A0-165C11FEF44DQ36885358-1A585847-932C-463E-83A2-D074A8A7B0F1Q36925888-FC397F84-494F-44A8-AAFF-9AB18732E023Q37420475-6E5B9B42-09BC-4FFA-83C9-FA10D1160A1BQ37705756-5DEFD0EF-AC81-4901-B7A4-993EB91EFB42Q37854476-4EFCF9AD-23A2-44C3-A223-2CA3E2725A45Q39209888-424B4228-047D-44C6-9DB3-8B4E31B5E811Q39385097-DDD4080B-AD5A-4DF9-9FF1-6CCF00EF5E61Q39433366-3F662F27-46FE-4477-B588-4051BB5B2680Q42689688-C0B8ACE3-6F9B-4697-B34D-BC33EB6FEB59Q47101962-8828B5ED-4754-4097-9C85-F3BD38BE63D6Q47555313-88A35D27-F3C0-4928-B4C4-72CECD92CA04Q53279360-EE026521-D1D2-4EB6-8F86-0186680DC15FQ55064984-893BEAA8-EA6B-404C-9A88-A2473526B55FQ55281800-0776B167-9BF7-4140-B69A-4B81899AA5A6Q55318003-4AB42B28-4FB0-4B2E-92FC-FE0B6B076E00Q58567918-B144A5BA-C992-464A-86CD-EDEDEF5E71D2
P2860
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Haloperidol for agitation in dementia.
@ast
Haloperidol for agitation in dementia.
@en
Haloperidol for agitation in dementia.
@nl
type
label
Haloperidol for agitation in dementia.
@ast
Haloperidol for agitation in dementia.
@en
Haloperidol for agitation in dementia.
@nl
altLabel
Haloperidol for agitation in dementia
@en
Haloperidol for agitation in dementia
@nl
prefLabel
Haloperidol for agitation in dementia.
@ast
Haloperidol for agitation in dementia.
@en
Haloperidol for agitation in dementia.
@nl
P1476
Haloperidol for agitation in dementia
@en
P2093
E Lonergan
J Luxenberg
P304
P356
10.1002/14651858.CD002852
P407
P50
P577
2002-01-01T00:00:00Z